Santa Farma Included in the TURQUALITY Program
Santa Farma, one of Türkiye's well-established, 100% domestically capitalized pharmaceutical companies, has crossed another historic threshold in its journey to becoming a global brand by being included in the TURQUALITY Support Program.
Santa Farma, a leading domestically-owned pharmaceutical company in Turkey, has been accepted into the TURQUALITY Support Programme, marking another historic milestone on its global brand journey.
Founded in 1944 in Edirnekapı and now managed by the third generation, Santa Farma advances with the vision of becoming "a reference company in healthcare that brings local market needs into line with global standards." The company is preparing to take the strength of the Turkish pharmaceutical industry to global markets.
Operating from a 40,000 square-metre modern production facility built on 80,000 square metres of land and hosting a research and development centre approved by the Turkish Ministry of Health, Santa Farma is strengthening its competitive position in international markets through TURQUALITY programme participation. The company will position its broad expertise ranging from acute products to the treatment of cardiometabolic diseases, and its pioneering role in introducing Turkey's first biotechnological drugs, more effectively on the global arena.
The five-year "Development Roadmap" developed under the TURQUALITY support programme will elevate Santa Farma's strategic partnerships and international expansion plans launched in Europe in 2020 to the next level. This period will provide strategic momentum to the company's vision of bringing local needs into line with global standards.
Sami Kiresepi: "Our vision is to become a reference company"
Santa Farma Chief Executive Officer Sami Kiresepi commented on the TURQUALITY achievement as follows:
"Our journey began over 80 years ago with our commitment to 'providing healthy service in healthcare,' and this commitment continues to guide our path today. Our acceptance into the TURQUALITY programme reflects the recognition our ethical values—which we have carefully upheld for three generations—and our production capacity are receiving on a global scale. With the visionary support this programme provides, we are combining the knowledge accumulated from our own soil with our overseas growth strategies. We are closer than ever to our goal of making Santa Farma a 'reference company'—a symbol of trust and science in global markets."
Gallery
